Eisele Jeffrey 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Eisele Jeffrey
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2023-01-27$52.77/sh−367$19,367→ 47,351 total
Footnotes (1)
- [F1]This represents shares withheld for tax on a restricted stock unit release.